Cargando…

The safety of cardioselective β(1)-blockers in asthma: literature review and search of global pharmacovigilance safety reports

INTRODUCTION: Beta-blockers are key in the management of cardiovascular diseases but blocking airway β(2)-receptors can cause severe and sometimes fatal bronchoconstriction in people with asthma. Although cardioselective β(1)-blockers may be safer than non-selective β-blockers, they remain relativel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bennett, Miriam, Chang, Catherina L., Tatley, Michael, Savage, Ruth, Hancox, Robert J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2021
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917232/ https://www.ncbi.nlm.nih.gov/pubmed/33681344 http://dx.doi.org/10.1183/23120541.00801-2020

Ejemplares similares

Cardioselective versus Non-Cardioselective Beta-Blockers and Outcomes in Patients with Atrial Fibrillation and Chronic Obstructive Pulmonary Disease
por: Vlachopoulou, Dimitra, et al.
Publicado: (2023)

An evaluation of the effects of nonselective and cardioselective β-blockers on wound healing in Sprague Dawley rats
por: Raut, Sanket B., et al.
Publicado: (2012)

Cardioselective peripheral noradrenergic deficiency in Lewy body synucleinopathies
por: Lamotte, Guillaume, et al.
Publicado: (2020)

Acebutolol, a Cardioselective Beta Blocker, Promotes Glucose Uptake in Diabetic Model Cells by Inhibiting JNK-JIP1 Interaction
por: Li, Yi, et al.
Publicado: (2018)

β-blockers in exacerbations of COPD: feasibility of a randomised controlled trial
por: Chang, Catherina L., et al.
Publicado: (2017)

Pharmacovigilance: Safety matters…
por: Biswas, Pipasha
Publicado: (2008)

Big data, medicines safety and pharmacovigilance
por: Hussain, Rabia
Publicado: (2021)

Diclofenac and the Risk of Rhabdomyolysis: Analysis of Publications and the WHO Global Pharmacovigilance Database
por: Russom, Mulugeta, et al.
Publicado: (2021)

The Global Vaccine Safety Initiative: enhancing vaccine pharmacovigilance capacity at country level
por: Maure, Christine G, et al.
Publicado: (2014)

Global safety monitoring of COVID-19 vaccines: how pharmacovigilance rose to the challenge
por: Rudolph, Annette, et al.
Publicado: (2022)

Case Series Analysis of New Zealand Reports of Rapid Intense Potentiation of Warfarin by Roxithromycin
por: Savage, Ruth L., et al.
Publicado: (2018)

Pharmacovigilance: Boon for the safety and efficacy of Ayuvedic formulations
por: Chaudhary, Anand, et al.
Publicado: (2010)

International Society of Pharmacovigilance monitors vaccine safety
Publicado: (2022)

Safety Profile of Ibrutinib: An Analysis of the WHO Pharmacovigilance Database
por: Allouchery, Marion, et al.
Publicado: (2021)

Biologics, Pharmacovigilance, and Patient Safety: It’s All in the Name
por: Stevenson, James G., et al.
Publicado: (2016)

Pharmacovigilance and drug safety 2011 in Calabria (Italy): Adverse events analysis
por: Scicchitano, Francesca, et al.
Publicado: (2012)

Pharmacovigilance and drug safety in Calabria (Italy): 2012 adverse events analysis
por: Giofrè, Chiara, et al.
Publicado: (2013)

Analysis of Reports Sent to the Portuguese Pharmacovigilance System and Published Literature Regarding the Safety of Metformin in the Elderly
por: Esteves, Beatriz, et al.
Publicado: (2023)

Measuring and Improving Physician Knowledge of Safety Risks Using Traditional and Online Methods in Pharmacovigilance
por: Liede, Alexander, et al.
Publicado: (2017)

Pharmacovigilance: A Worldwide Master Key for Drug Safety Monitoring
por: Jeetu, G, et al.
Publicado: (2010)

Pharmacovigilance and assessment of drug safety reports during COVID 19
por: Desai, Mira K
Publicado: (2020)

Safety of Inulin and Sinistrin: Combining Several Sources for Pharmacovigilance Purposes
por: Bui, T-V., et al.
Publicado: (2021)

Safety of trastuzumab deruxtecan: A meta‐analysis and pharmacovigilance study
por: Guo, Zihan, et al.
Publicado: (2022)

Improved drug safety through intensive pharmacovigilance in hospitalized pediatric patients
por: Vázquez-Alvarez, Alan O., et al.
Publicado: (2017)

Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study
por: Barbieri, Maria Antonietta, et al.
Publicado: (2020)

Pharmacovigilance and Pharmacoepidemiology as a Guarantee of Patient Safety: The Role of the Clinical Pharmacologist
por: Crescioli, Giada, et al.
Publicado: (2022)

Safety of Non-Steroidal Anti-Inflammatory Drugs in the Elderly: An Analysis of Published Literature and Reports Sent to the Portuguese Pharmacovigilance System
por: Monteiro, Cristina, et al.
Publicado: (2022)

Safety monitoring of local anaesthetic drugs from the perspective of Pharmacovigilance Programme of India
por: Kumar, Pramod, et al.
Publicado: (2017)

Pharmacovigilance Agreements: Negotiating Safety Data Exchange Timelines: To Agree to Disagree? That is the Question
por: Manko Singer, Wendy, et al.
Publicado: (2023)

Safety of sublingual immunotherapy for asthma with standardized house dust mite vaccines in a tropical setting: Results of a nation-wide pharmacovigilance study
por: Morejón, Maytee Mateo, et al.
Publicado: (2015)

Using Twitter Data for Cohort Studies of Drug Safety in Pregnancy: Proof-of-concept With β-Blockers
por: Klein, Ari Z, et al.
Publicado: (2022)

The Global Perspective of Pharmacovigilance in Nuclear Medicine Practice
por: Meher, Bikash Ranjan, et al.
Publicado: (2018)

Global pharmacovigilance regulations: Call for re-harmonization
por: Singh, Ajay, et al.
Publicado: (2018)

Pharmacovigilance: A Worldwide Master Key for Drug Safety Monitoring: Some Additional Information
por: Patel, C
Publicado: (2011)

Safety Concerns with HPV Vaccines Continue to Linger: Are Current Vaccine Pharmacovigilance Practices Sufficient?
por: Chandler, Rebecca E.
Publicado: (2017)

Reporting of Safety Events during Anti-VEGF Treatment: Pharmacovigilance in a Noninterventional Trial
por: Ziemssen, Focke, et al.
Publicado: (2020)

Safety profile of biologic drugs for psoriasis in clinical practice: An Italian prospective pharmacovigilance study
por: Iannone, Luigi Francesco, et al.
Publicado: (2020)

Evaluation of the safety profile of rotavirus vaccines: a pharmacovigilance analysis on American and European data
por: Bonaldo, Giulia, et al.
Publicado: (2020)

Practical considerations for creating a strategic and proactive clinical safety and pharmacovigilance organization for the future
por: Nord, Magnus, et al.
Publicado: (2021)

Guiding axes for drug safety management of pharmacovigilance centres during the COVID-19 era
por: Ferreira-da-Silva, Renato, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dpkbll7n0u5ml3v1mqet1qj32u